* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, June 26, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

    Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

    George Lopez is coming to Spokane – KXLY.com

    George Lopez is coming to Spokane – KXLY.com

    Netflix unveils Dallas immersive venue for fans of hit shows like ‘Squid Game,’ ‘Stranger Things’ – Houston Chronicle

    Step Inside Netflix’s New Dallas Immersive Experience Featuring Hits Like ‘Squid Game’ and ‘Stranger Things

    ‘Puttin’ on the Ritz’: Civic Players bring ‘Young Frankenstein’ to life – Yahoo

    Civic Players Deliver a Hilarious and Unforgettable Performance of ‘Young Frankenstein

    ‘Wheel of Fortune’: Amputee Wins $60,000 After Breaking Incredible ‘Curse’ – Hastings Tribune

    Wheel of Fortune’ Amputee Breaks Incredible ‘Curse’ to Win $60,000!

    North Star Sports & Entertainment Network: Coming soon – KTTC News

    North Star Sports & Entertainment Network: Coming soon – KTTC News

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Wayve Expands Engineering Leadership to Power Next-Gen Autonomous Driving Technology – Silicon Canals

    Wayve Boosts Engineering Leadership to Accelerate Next-Gen Autonomous Driving Innovation

    Frontdoor Announces Tech Expert Dr. Bala Ganesh as Chief Technology Officer – Business Wire

    Frontdoor Appoints Tech Visionary Dr. Bala Ganesh as New Chief Technology Officer

    Defense technology giant Northrop Grumman to host interviews in Iuka to fill technician roles – supertalk.fm

    Defense technology giant Northrop Grumman to host interviews in Iuka to fill technician roles – supertalk.fm

    China’s Military Introduces Mosquito-Sized Drones: A Game-Changing Surveillance Technology – Indian Defence Review

    China Unveils Mosquito-Sized Drones: Revolutionizing Surveillance Technology

    Marvell Technology Stock Rallies After AI Event Sparks Investor Optimism – Yahoo Finance

    Marvell Technology Stock Rallies After AI Event Sparks Investor Optimism – Yahoo Finance

    Promising Technology Stocks To Follow Today – June 22nd – MarketBeat

    Top Technology Stocks to Watch Today – June 22nd

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

    Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

    George Lopez is coming to Spokane – KXLY.com

    George Lopez is coming to Spokane – KXLY.com

    Netflix unveils Dallas immersive venue for fans of hit shows like ‘Squid Game,’ ‘Stranger Things’ – Houston Chronicle

    Step Inside Netflix’s New Dallas Immersive Experience Featuring Hits Like ‘Squid Game’ and ‘Stranger Things

    ‘Puttin’ on the Ritz’: Civic Players bring ‘Young Frankenstein’ to life – Yahoo

    Civic Players Deliver a Hilarious and Unforgettable Performance of ‘Young Frankenstein

    ‘Wheel of Fortune’: Amputee Wins $60,000 After Breaking Incredible ‘Curse’ – Hastings Tribune

    Wheel of Fortune’ Amputee Breaks Incredible ‘Curse’ to Win $60,000!

    North Star Sports & Entertainment Network: Coming soon – KTTC News

    North Star Sports & Entertainment Network: Coming soon – KTTC News

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Wayve Expands Engineering Leadership to Power Next-Gen Autonomous Driving Technology – Silicon Canals

    Wayve Boosts Engineering Leadership to Accelerate Next-Gen Autonomous Driving Innovation

    Frontdoor Announces Tech Expert Dr. Bala Ganesh as Chief Technology Officer – Business Wire

    Frontdoor Appoints Tech Visionary Dr. Bala Ganesh as New Chief Technology Officer

    Defense technology giant Northrop Grumman to host interviews in Iuka to fill technician roles – supertalk.fm

    Defense technology giant Northrop Grumman to host interviews in Iuka to fill technician roles – supertalk.fm

    China’s Military Introduces Mosquito-Sized Drones: A Game-Changing Surveillance Technology – Indian Defence Review

    China Unveils Mosquito-Sized Drones: Revolutionizing Surveillance Technology

    Marvell Technology Stock Rallies After AI Event Sparks Investor Optimism – Yahoo Finance

    Marvell Technology Stock Rallies After AI Event Sparks Investor Optimism – Yahoo Finance

    Promising Technology Stocks To Follow Today – June 22nd – MarketBeat

    Top Technology Stocks to Watch Today – June 22nd

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

ASCT Tops CAR T-Cell Therapy for Relapsed LBCL in Complete Remission

December 11, 2023
in Health
ASCT Tops CAR T-Cell Therapy for Relapsed LBCL in Complete Remission
Share on FacebookShare on Twitter

SAN DIEGO — Autologous stem-cell transplantation (ASCT) led to improved outcomes as compared with CAR T-cell therapy for patients with relapsed large B-cell lymphoma (LBCL) in complete remission, a retrospective analysis showed.

Patients who underwent ASCT had fewer relapses at 2 years (27.8% vs 48.0%) and better progression-free survival (PFS, 66.2% vs 47.8%), and overall survival (OS, 78.9% vs 65.6%). In the subgroup of patients with early treatment failure, ASCT was associated with a lower 2-year relapse rate (22.8% vs 45.9%). Treatment-related mortality did not differ between the two types of treatment.

By multivariate analysis, CAR T-cell therapy was associated with a higher risk of relapse and inferior PFS, reported Mazyar Shadman, MD, of the University of Washington and Fred Hutchinson Cancer Center in Seattle, at the American Society of Hematology (ASH) meeting.

“The message here is that this data could be practice informing and confirming,” Shadman said during an ASH press briefing. “In patients who relapse after first-line therapy after 12 months, the current standard of care is salvage therapy with autotransplant. This data confirms that. There’s currently no data suggesting that patients who are in CR [complete remission] should receive CAR-T therapy in that setting.”

“The goal of therapy should be CAR-T therapy, and all efforts should be made to improve access to CAR-T,” he continued. “Until then, for patients who achieve a good clinical response, an autotransplant [ASCT] strategy could be a reasonable option to discuss … and could add another potentially curative therapy for these patients, knowing that CAR-T could still be utilized in the later line of therapy if autotransplant fails the patient.”

LBCL in CR

During a discussion that followed the presentation, Shadman emphasized that the study involved patients who were in CR after initial relapse. Patients referred for CAR T-cell therapy often receive chemotherapy during the interval when cells are being processed for infusion.

“We don’t expect these patients to respond to subsequent chemotherapy because they have already shown that they don’t do well with chemotherapy,” he said. “However, some do. Sometimes we see after one or two cycles of chemotherapy, their disease goes away. They’re in complete remission.

“The [situation raises] a practical question. This patient has very chemo-sensitive disease. We know that they do well with autotransplant, so what do we do now? Still send them for CAR-T? Maybe try autotransplant because we know they can be cured with autotransplant, and if autotransplant doesn’t work, you still have CAR-T as your backup plan.”

For patients with primary refractory disease, CAR T-cell therapy is the treatment of choice in second line.

“We are not suggesting that these patients should be sent for autotransplant,” said Shadman.

The discussion led to comments about the FDA’s recent safety communication regarding a potential risk of secondary malignancies with CAR T-cell therapy.

“Do you think more of these CAR T-cell-related malignancies will emerge and is that further justification for pivoting toward autologous transplant in these patients?” asked press briefing moderator Mikkael Sekeres, MD, of the University of Miami Sylvester Comprehensive Cancer Center.

Shadman said he and other CAR T-cell investigators know little about the issue beyond what the FDA has communicated.

“The number of secondary cancers that may be directly related to CAR-T is extremely low compared to the benefit that CAR-T provides in curing a very high percentage of patients who have no other options,” said Shadman. “I don’t think that the signal — which is very important and should be followed and will be followed — will change anything in our practice in offering curative therapy for relapsed lymphoma.”

High-dose chemotherapy, often used in conjunction with ASCT, also is associated with secondary malignancies, he added.

Background, Key Findings

CAR T-cell therapy has become standard of care for relapsed LBCL as early as second line. In clinical practice, access to CAR T-cell therapy might be delayed because of logistical issues, and in the interim, patients may receive bridging chemotherapy. Some of the patients achieve a partial or complete response. Several reports have shown that CAR T-cell therapy is safety and active in patients who achieve a complete response with bridging therapy, said Shadman.

Additionally, Shadman and colleagues recently reported the superiority of ASCT over CAR T-cell therapy in patients with LBCL in partial remission.

The observations provided the basis for a retrospective comparison of outcomes with ASCT and CAR T-cell therapy in patients with LBCL in CR. Investigators hypothesized that transplant would be superior in that setting.

Data for the study came from the Center for International Blood & Marrow Transplant Research registry. The analysis included adults with diffuse LBCL in CR, treated with CAR T-cell therapy from 2018-2021 (n=79) or ASCT from 2015-2021 (n=281). Median follow-up was 24.7 months for CAR-T and 49.7 months for ASCT. The primary endpoints were PFS and OS.

The results favored ASCT for most outcomes:

2-year PFS: 66.2% vs 47.8% (P
>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/meetingcoverage/ashhematology/107780

Tags: healthT-CellTherapy
Previous Post

‘New Gold Standard’ for Previously Untreated CLL

Next Post

U.S. Drinking-Water Systems Still Haven’t Defeated This Nasty Parasite

Wayve Expands Engineering Leadership to Power Next-Gen Autonomous Driving Technology – Silicon Canals

Wayve Boosts Engineering Leadership to Accelerate Next-Gen Autonomous Driving Innovation

June 26, 2025
Fantasy Football: Which teams are set to pass the most (and least) in 2025? – Yahoo Sports

Fantasy Football Preview: Which Teams Will Lead the League in Passing Attempts in 2025?

June 26, 2025
Tiny night lizards survived dinosaur-killing asteroid strike, despite being close enough to see it happen – Live Science

How Tiny Night Lizards Defied Extinction After the Dinosaur-Killing Asteroid Impact

June 26, 2025
Scientists Confirm Anti-Aging Drug Appears to Prolong Life in Animals – ScienceAlert

Scientists Confirm Anti-Aging Drug Appears to Prolong Life in Animals – ScienceAlert

June 26, 2025
Tokyo Lifestyle Makes Strategic Move into Australian Market with Premium Store in Sydney Chinatown – Stock Titan

Tokyo Lifestyle Makes Strategic Move into Australian Market with Premium Store in Sydney Chinatown – Stock Titan

June 26, 2025
First images from world’s largest digital camera reveal galaxies and cosmic collisions – NBC News

First images from world’s largest digital camera reveal galaxies and cosmic collisions – NBC News

June 26, 2025
Spirit Airlines Rebrands Travel Options: First, Premium Economy, Value – One Mile at a Time

Spirit Airlines Unveils Exciting New Travel Options: First, Premium Economy, and Value Classes

June 26, 2025
Susquehanna Raises Penn Entertainment Inc. (PENN) Price Target. – Yahoo Finance

Susquehanna Raises Price Target for Penn Entertainment Inc. (PENN)

June 26, 2025

Vanderburgh County Health Department Takes Bold Action Against Vaccine Hesitancy

June 26, 2025
Why Trump needs the world to believe Iran’s nuclear program is ‘obliterated’ – CNN

Why Trump Wants the World to Believe Iran’s Nuclear Program Is Completely Destroyed

June 26, 2025

Categories

Archives

June 2025
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« May    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (698)
  • Economy (718)
  • Entertainment (21,613)
  • General (15,576)
  • Health (9,757)
  • Lifestyle (723)
  • News (22,149)
  • People (720)
  • Politics (725)
  • Science (15,936)
  • Sports (21,215)
  • Technology (15,703)
  • World (698)

Recent News

Wayve Expands Engineering Leadership to Power Next-Gen Autonomous Driving Technology – Silicon Canals

Wayve Boosts Engineering Leadership to Accelerate Next-Gen Autonomous Driving Innovation

June 26, 2025
Fantasy Football: Which teams are set to pass the most (and least) in 2025? – Yahoo Sports

Fantasy Football Preview: Which Teams Will Lead the League in Passing Attempts in 2025?

June 26, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version